Stockreport

Press Release: Sanofi's efdoralprin alfa earns orphan designation in the EU for alpha-1 antitrypsin deficiency related emphysema [Yahoo! Finance]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Additional orphan designation reinforces Sanofi's commitment to developing treatments for rare diseases Efdoralprin alfa, an investigational restorative recombinant t [Read more]